# Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

> **NCT04489745** · PHASE2 · UNKNOWN · sponsor: **VA Greater Los Angeles Healthcare System** · enrollment: 72 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** SBRT
- **DRUG:** Androgen deprivation therapy (ADT)

## Key facts

- **NCT ID:** NCT04489745
- **Lead sponsor:** VA Greater Los Angeles Healthcare System
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2022-01
- **Final completion:** 2025-01
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2020-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04489745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04489745, "Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04489745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*